VICKI REDPATH: Open Payments
NPI 1326570961 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,338 in 70 payments from 9 companies in 2025. Trend: 2023 $3,229 · 2024 $3,315 · 2025 $3,338
Food & beverage: $2,814Consulting: $524
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $923 |
| Celltrion USA Inc. | 3 | $683 |
| Janssen Biotech, Inc. | 12 | $612 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $437 |
| Janssen Scientific Affairs, LLC | 3 | $356 |
| Lilly USA, LLC | 5 | $124 |
| PFIZER INC. | 4 | $75 |
| Aimmune Therapeutics, Inc. | 3 | $66 |
| Organon LLC | 4 | $62 |
Products named: TREMFYA, ZYMFENTRA, SKYRIZI, RINVOQ, ENTYVIO, OMVOH, GATTEX, VELSIPITY.
Industry payments across TX — which companies pay providers there.
